Joseph P. Lucia & Associates, LLC Aldeyra Therapeutics, Inc. Transaction History
Joseph P. Lucia & Associates, LLC
- $192 Million
- Q4 2024
A detailed history of Joseph P. Lucia & Associates, LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Joseph P. Lucia & Associates, LLC holds 31,670 shares of ALDX stock, worth $158,350. This represents 0.08% of its overall portfolio holdings.
Number of Shares
31,670
Previous 31,732
0.2%
Holding current value
$158,350
Previous $171,000
7.6%
% of portfolio
0.08%
Previous 0.09%
Shares
7 transactions
Others Institutions Holding ALDX
# of Institutions
117Shares Held
36.2MCall Options Held
196KPut Options Held
142K-
Perceptive Advisors LLC New York, NY9.28MShares$46.4 Million1.31% of portfolio
-
Knoll Capital Management, LLC Miami, FL5.48MShares$27.4 Million14.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.76MShares$18.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$18.1 Million0.0% of portfolio
-
Kennedy Capital Management, Inc. St Louis, MO1.88MShares$9.41 Million0.24% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $292M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...